52 related articles for article (PubMed ID: 36722270)
1. Construction of an Immunity and Ferroptosis-Related Risk Score Model to Predict Ovarian Cancer Clinical Outcomes and Immune Microenvironment.
Wei C; Zhao G; Gao M; Liu Y; Lei P; Cao T
Front Biosci (Landmark Ed); 2023 Jan; 28(1):4. PubMed ID: 36722270
[TBL] [Abstract][Full Text] [Related]
2. Construction of Ovarian Cancer Prognostic Model Based on the Investigation of Ferroptosis-Related lncRNA.
Yang S; Ji J; Wang M; Nie J; Wang S
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830675
[TBL] [Abstract][Full Text] [Related]
3. A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer.
Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Wang Y
J Ovarian Res; 2023 Apr; 16(1):86. PubMed ID: 37120633
[TBL] [Abstract][Full Text] [Related]
4. A lactate metabolism-related signature predicting patient prognosis and immune microenvironment in ovarian cancer.
Zhu L; Lin Z; Wang K; Gu J; Chen X; Chen R; Wang L; Cheng X
Front Endocrinol (Lausanne); 2024; 15():1372413. PubMed ID: 38529390
[TBL] [Abstract][Full Text] [Related]
5. A Novel Notch-Related Gene Signature for Prognosis and Immune Response Prediction in Ovarian Cancer.
Pi Y; Sun F; Zhang Z; Liu X; Lou G
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512088
[No Abstract] [Full Text] [Related]
6. Identification and validation of an immunotherapeutic signature for colon cancer based on the regulatory patterns of ferroptosis and their association with the tumor microenvironment.
Liu Y; Zhao J; Huang B; Liang Y; Jiang G; Zhou X; Chen Y; He T; Zheng M; Huang Z
Biochim Biophys Acta Mol Cell Res; 2024 Apr; 1871(4):119698. PubMed ID: 38387508
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential key genes of TGF-beta signaling associated with the immune response and prognosis of ovarian cancer based on bioinformatics analysis.
Zhang X; Han L; Zhang H; Niu Y; Liang R
Heliyon; 2023 Aug; 9(8):e19208. PubMed ID: 37664697
[TBL] [Abstract][Full Text] [Related]
8. Development of an immune-related gene prognostic risk model and identification of an immune infiltration signature in the tumor microenvironment of colon cancer.
Hao M; Li H; Yi M; Zhu Y; Wang K; Liu Y; Liang X; Ding L
BMC Gastroenterol; 2023 Mar; 23(1):58. PubMed ID: 36890467
[TBL] [Abstract][Full Text] [Related]
9. Leucyl and Cystinyl Aminopeptidase as a Prognostic-Related Biomarker in OV Correlating with Immune Infiltrates.
Ma Q; Chang L; Wang W; Che L; Song X; Li G; Zhang Y; Chen Y; Gu Z; Ge X
Pharmgenomics Pers Med; 2023; 16():551-568. PubMed ID: 37293607
[TBL] [Abstract][Full Text] [Related]
10. Necroptosis-Related Modification Patterns Depict the Tumor Microenvironment, Redox Stress Landscape, and Prognosis of Ovarian Cancer.
Geng R; Zhong Z; Ni S; Liu W; He Z; Gan S; Huang Q; Yu H; Bai J; Liu J
Oxid Med Cell Longev; 2023; 2023():4945288. PubMed ID: 37082103
[TBL] [Abstract][Full Text] [Related]
11. Application of single-cell RNA sequencing analysis of novel breast cancer phenotypes based on the activation of ferroptosis-related genes.
Liu S; Zhao Y; Zhang J; Liu Z
Funct Integr Genomics; 2023 May; 23(2):173. PubMed ID: 37212877
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis-related genes in cervical cancer as biomarkers for predicting the prognosis of gynecological tumors.
Han S; Wang S; Lv X; Li D; Feng Y
Front Mol Biosci; 2023; 10():1188027. PubMed ID: 37187896
[No Abstract] [Full Text] [Related]
13. An artificial intelligence prediction model based on extracellular matrix proteins for the prognostic prediction and immunotherapeutic evaluation of ovarian serous adenocarcinoma.
Geng T; Zheng M; Wang Y; Reseland JE; Samara A
Front Mol Biosci; 2023; 10():1200354. PubMed ID: 37388244
[No Abstract] [Full Text] [Related]
14. Ferroptosis: Promising approach for cancer and cancer immunotherapy.
Zheng S; Guan XY
Cancer Lett; 2023 May; 561():216152. PubMed ID: 37023938
[TBL] [Abstract][Full Text] [Related]
15. Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma.
Li L; Zhang W; Qiu J; Zhang W; Lu M; Wang J; Jin Y; Xi Q
Stem Cells Int; 2023; 2023():4500561. PubMed ID: 37168445
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors.
Cai H; Ren Y; Chen S; Wang Y; Chu L
Front Oncol; 2023; 13():1119369. PubMed ID: 36845720
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of N6‑methyladenosine modification in tumor development and potential therapeutic strategies (Review).
Pu X; Wu Y; Ji Q; Fu S; Zuo H; Chu L; Tang H; Wan M; Wang X; Xu M
Int J Oncol; 2023 Jun; 62(6):. PubMed ID: 37203412
[TBL] [Abstract][Full Text] [Related]
18. By using machine learning and
Xia G; Wu S; Luo K; Cui X
Front Oncol; 2023; 13():1180191. PubMed ID: 37091161
[TBL] [Abstract][Full Text] [Related]
19. Unique tumour microenvironment: when ferroptosis activation boosts ICI of liver cancer.
Ramadori P; Gallage S; Heikenwälder MF
Gut; 2023 Sep; 72(9):1639-1641. PubMed ID: 37321831
[No Abstract] [Full Text] [Related]
20. Ferroptosis: friend or foe in cancer immunotherapy?
Demuynck R; Efimova I; Catanzaro E; Krysko DV
Oncoimmunology; 2023; 12(1):2182992. PubMed ID: 36875549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
